DEPRESSION OF THEOPHYLLINE ELIMINATION BY ERYTHROMYCIN

被引：79

作者：

RENTON, KW ^{[1
]}

GRAY, JD ^{[1
]}

HUNG, OR ^{[1
]}

机构：

[1] DALHOUSIE UNIV,DEPT MED,HALIFAX B3H 4H7,NS,CANADA

来源：

关键词：

D O I：

10.1038/clpt.1981.182

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：422 / 426

页数：5

共 17 条

[1] CHANG KC, 1978, LANCET, V1, P1132
[2] COCACE LG, 1977, DRUG INTELL CLIN PHA, V11, P22
[3] CUMMINS LH, 1977, PEDIATRICS, V59, P144
[4] GRYGIEL JJ, 1979, CLIN PHARMACOL THER, V26, P660
[5] DEPRESSION OF THEOPHYLLINE METABOLISM AND ELIMINATION BY TROLEANDOMYCIN AND ERYTHROMYCIN
HEMSWORTH, TC
RENTON, KW
[J]. BIOCHEMICAL PHARMACOLOGY, 1981, 30 (11) : 1299 - 1304
[6] AVOIDANCE OF ADVERSE-EFFECTS DURING CHRONIC THERAPY WITH THEOPHYLLINE
HENDELES, L
WEINBERGER, M
[J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1980, 14 (7-8): : 522 - 530
[7] ADMINISTRATION OF ERYTHROMYCIN TO PATIENTS ON THEOPHYLLINE
KOZAK, PP
CUMMINS, LH
GILLMAN, SA
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1977, 60 (02) : 149 - 151
[8] DOSE-DEPENDENT ELIMINATION KINETICS OF THEOPHYLLINE
LESKO, LJ
[J]. CLINICAL PHARMACOKINETICS, 1979, 4 (06) : 449 - 459
[9] LOHMANN SM, 1976, J PHARMACOL EXP THER, V196, P213
[10] INHIBITION OF THEOPHYLLINE METABOLISM BY LONG-TERM ALLOPURINOL ADMINISTRATION
MANFREDI, RL
VESELL, ES
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (02) : 224 - 229